The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab plus lenvatinib (P+L) versus alternative therapies in first-line (1L) advanced renal cell carcinoma (aRCC) by IMDC risk status: A network meta-analysis (NMA).
 
Pratik Rane
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Kevin Yan
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
Research Funding - Merck (Inst)
 
Manuela Schmidinger
Honoraria - AstraZeneca; BMS; EISAI; EUSA Pharma; Ipsen; Janssen Oncology; Merck Sharp & Dohme; MSD Oncology
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; EUSA Pharma; Ipsen; MSD Oncology
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; Ipsen
 
Avivit Peer
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Exelixis; Janssen Oncology; Medison; Merck Serono; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Eisai; Janssen-Cilag; Merck Serono; MSD Oncology; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; BMS; MSD; Pfizer
Other Relationship - AstraZeneca
 
Eric Druyts
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
Research Funding - Merck Sharp & Dohme (Inst)
 
Joseph E. Burgents
Employment - Merck
Stock and Other Ownership Interests - Merck; Merck (I)
 
Murali Sundaram
Employment - Merck
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Johnson & Johnson; Merck
Travel, Accommodations, Expenses - Merck
Other Relationship - Merck